U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07395596) titled 'Remimazolam for Bronchoscopy in High-Risk Patients' on July 07, 2025.
Brief Summary: Bronchoscopy is currently widely used for the diagnosis and treatment of various respiratory diseases. However, the operation of bronchoscopy is irritating, causes a strong stress response, and shares the airway with the patient, making the patient highly susceptible to respiratory and cardiovascular risks. Among these risks, hypoxia is the most common adverse event.Different drug regimens can be selected for anesthesia under deep sedation. The combination of analgesic agents can help reduce coughing during bronchoscopy. Therefore, we employ a combi...